10-Q quarterly report · filed Nov 9, 2026

GeneDx Holdings Corp. (WGS) Q3 2026 10-Q Quarterly Report

Short answer

GeneDx Holdings Corp. (WGS) filed its Q3 2026 10-Q quarterly report on Nov 9, 2026 for the quarter ended Sep 30, 2026. Quarterly revenue was $123M (up 5.4% year over year) with net income of −$12M.

Q3 2026 key financials · XBRL

Revenue
$123M
+5.4% YoY · +7.6% QoQ
Net income
−$12M
−61.5% YoY · +30.5% QoQ
Operating margin
-8.5%
Gross margin
69.9%
EPS (diluted)
−$0.40
−53.8% YoY · +32.2% QoQ

Source: XBRL data from the GeneDx Holdings Corp. (WGS) Q3 2026 10-Q on SEC EDGAR. USD.

GeneDx Holdings Corp. Q3 2026 10-Q analysis

AI summary of MD&A and risk factor updates

Management Discussion & Analysis

  • Q3 revenue $123.1M, up 5% YoY from $116.7M, driven by diagnostic test revenue of $120.1M
  • Gross margin 69.9% vs 72.4% YoY, with net loss $12.3M vs $7.6M
  • Best performer: whole exome and genome sequencing revenue up 12%, test volumes up 25%
  • Cash and securities $170.1M; operating cash flow $(72.0)M vs $36.4M YoY
  • Capital deployment: $150.0M Blackstone borrowing, $5.0M stock issuance, $21.8M property and software investment

Risk Factors

  • New PAMA rate risk triggered by September 2026 preliminary weighted medians, with many codes facing reductions beginning January 1, 2027
  • Most material update: cumulative PAMA cuts could continue through 2029, increasing aggregate financial impact over the phase-in period
  • Regulatory risk: laboratories face substantial civil money penalties for failing to report or erroneously reporting private-payor data
  • Revenue risk: Medicare coverage represents a significant patient base, making CMS reimbursement reductions especially impactful
  • Policy uncertainty: Congress may enact the RESULTS Act or other PAMA reforms before January 1, 2027

Generated from the filing text; verify against the original. 10-K vs 10-Q vs 8-K

Other GeneDx Holdings Corp. quarterly reports

Ask about this quarter

Compare quarters, check guidance or see what insiders and funds did around the report.